Elite Pharmaceuticals, Inc. (ELTP)
OTCMKTS
· Delayed Price · Currency is USD
0.550
-0.020 (-3.51%)
Dec 20, 2024, 4:00 PM EST
Elite Pharmaceuticals Balance Sheet
Financials in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
Cash & Equivalents | 9.55 | 7.11 | 7.83 | 8.54 | 3.19 | 1.13 | Upgrade
|
Cash & Short-Term Investments | 9.55 | 7.11 | 7.83 | 8.54 | 3.19 | 1.13 | Upgrade
|
Cash Growth | 10.41% | -9.27% | -8.24% | 167.33% | 182.11% | -50.31% | Upgrade
|
Receivables | 21.44 | 19.45 | 3.09 | 3.06 | 3.5 | 4.11 | Upgrade
|
Inventory | 14.16 | 12.93 | 9.55 | 6.74 | 5.01 | 4.14 | Upgrade
|
Prepaid Expenses | 0.13 | 0.52 | 1.03 | 0.53 | 0.49 | 0.87 | Upgrade
|
Total Current Assets | 45.29 | 40.01 | 21.51 | 18.86 | 12.19 | 10.25 | Upgrade
|
Property, Plant & Equipment | 14.28 | 14.61 | 10.44 | 6.98 | 6.86 | 7.59 | Upgrade
|
Other Intangible Assets | 0.29 | 0.29 | 0.29 | 0.47 | 0.47 | 0.47 | Upgrade
|
Long-Term Deferred Tax Assets | 20.84 | 22.16 | 2.17 | 2.17 | - | - | Upgrade
|
Long-Term Deferred Charges | 6.95 | 6.05 | 6.05 | 6.17 | 6.17 | 6.17 | Upgrade
|
Other Long-Term Assets | 0.54 | 0.53 | 0.43 | 0.5 | 0.5 | 0.48 | Upgrade
|
Total Assets | 88.2 | 83.65 | 40.9 | 35.15 | 26.19 | 24.96 | Upgrade
|
Accounts Payable | 1.98 | 2.71 | 2.45 | 1.43 | 0.93 | 1.58 | Upgrade
|
Accrued Expenses | 5.28 | 4.82 | 4.63 | 4.28 | 4.27 | 4.82 | Upgrade
|
Short-Term Debt | 4 | 4 | - | - | - | - | Upgrade
|
Current Portion of Long-Term Debt | 0.37 | 0.3 | 0.31 | 0.35 | 0.41 | 1.85 | Upgrade
|
Current Portion of Leases | 0.79 | 0.72 | 0.01 | 0.2 | 0.19 | 0.21 | Upgrade
|
Current Income Taxes Payable | 0.42 | 0.49 | 0.41 | 0.41 | - | - | Upgrade
|
Current Unearned Revenue | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.18 | Upgrade
|
Total Current Liabilities | 12.85 | 13.05 | 7.83 | 6.69 | 5.81 | 8.64 | Upgrade
|
Long-Term Debt | 3.08 | 3.28 | 3.56 | 1.39 | 1.74 | 1.8 | Upgrade
|
Long-Term Leases | 3.17 | 3.44 | - | 0.84 | 0.04 | 0.17 | Upgrade
|
Long-Term Unearned Revenue | - | 0.01 | 0.02 | 0.03 | 0.05 | 0.06 | Upgrade
|
Other Long-Term Liabilities | 21.84 | 6.3 | 0.52 | 0.98 | 2.4 | 3.63 | Upgrade
|
Total Liabilities | 40.93 | 26.07 | 11.94 | 9.93 | 10.04 | 14.3 | Upgrade
|
Common Stock | 1.07 | 1.07 | 1.01 | 1.01 | 1.01 | 0.84 | Upgrade
|
Additional Paid-In Capital | 173.32 | 173.21 | 164.75 | 164.58 | 164.41 | 150.26 | Upgrade
|
Retained Earnings | -126.81 | -116.39 | -136.5 | -140.06 | -148.96 | -154.05 | Upgrade
|
Treasury Stock | -0.31 | -0.31 | -0.31 | -0.31 | -0.31 | -0.31 | Upgrade
|
Total Common Equity | 47.27 | 57.58 | 28.96 | 25.22 | 16.15 | -3.25 | Upgrade
|
Shareholders' Equity | 47.27 | 57.58 | 28.96 | 25.22 | 16.15 | 10.66 | Upgrade
|
Total Liabilities & Equity | 88.2 | 83.65 | 40.9 | 35.15 | 26.19 | 24.96 | Upgrade
|
Total Debt | 11.4 | 11.74 | 3.89 | 2.78 | 2.38 | 4.03 | Upgrade
|
Net Cash (Debt) | -1.84 | -4.63 | 3.94 | 5.75 | 0.81 | -2.9 | Upgrade
|
Net Cash Growth | - | - | -31.44% | 606.63% | - | - | Upgrade
|
Net Cash Per Share | -0.00 | -0.00 | 0.00 | 0.01 | 0.00 | -0.00 | Upgrade
|
Filing Date Shares Outstanding | 1,068 | 1,068 | 1,014 | 1,011 | 1,009 | 840.4 | Upgrade
|
Total Common Shares Outstanding | 1,068 | 1,068 | 1,014 | 1,011 | 1,009 | 840.4 | Upgrade
|
Working Capital | 32.44 | 26.96 | 13.68 | 12.17 | 6.38 | 1.61 | Upgrade
|
Book Value Per Share | 0.04 | 0.05 | 0.03 | 0.02 | 0.02 | -0.00 | Upgrade
|
Tangible Book Value | 46.98 | 57.29 | 28.67 | 24.76 | 15.69 | -3.71 | Upgrade
|
Tangible Book Value Per Share | 0.04 | 0.05 | 0.03 | 0.02 | 0.02 | -0.00 | Upgrade
|
Land | 11.65 | 11.06 | 10.77 | 5.46 | 5.46 | 5.26 | Upgrade
|
Machinery | 14.95 | 15.02 | 14.24 | 13.85 | 13.35 | 12.92 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.